Skip to main content

Find Clinical Trials

Home
Conditions
Neurodegenerative Diseases

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,069 public trials 1,779 recruiting studies

Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Terminated

A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

NCT05328908

Conditions: Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +18 more
Locations: Local Institution - 0044 Springdale, Arkansas, United States

Local Institution - 0012 Los Angeles, California, United States

Local Institution - 0117 Norwich, Connecticut, United States

Local Institution - 0025 Miami, Florida, United States

View all 139 locations

View Trial Details

Terminated

Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas

NCT05130866

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations: House Institute Los Angeles, California, United States

University of California Los Angeles Los Angeles, California, United States

Children's National Hospital Washington D.C., District of Columbia, United States

University of Florida Gainesville, Florida, United States

View all 15 locations

View Trial Details

Terminated

Augmented Reality Treadmill Training in Patients With Parkinson's Disease

NCT04108741

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Department of Neurology Valens, Canton of St. Gallen, Switzerland

View Trial Details

Suspended

Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)

NCT07102212

Conditions: Alzheimer Disease, Anxiety Disorders, Behavior, +56 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Withdrawn

High-Altitude Neurodegeneration Cohort (HANC) Study

NCT07657520

Conditions: Altitude Sickness, Autonomic Nervous System Diseases, Basal Ganglia Diseases, +10 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Withdrawn

Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.

NCT05931484

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details

Withdrawn

Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3

NCT04637282

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations: Not specified

View Trial Details

Withdrawn

A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

NCT07075627

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Bronchial Neoplasms, +21 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Withdrawn

Perceptual Decision Making Under Conditions of Visual Uncertainty

NCT01845883

Conditions: Ataxia, Basal Ganglia Diseases, Brain Diseases, +13 more
Locations: Neuroscience Research Building Los Angeles, California, United States

View Trial Details